News about Biotechnology

LANXESS disinfectant kills coronavirus SARS-CoV-2 in just 60 seconds

LANXESS disinfectant kills coronavirus SARS-CoV-2 in just 60 seconds

Rely+On Virkon achieved rapid and complete inactivation of the SARS-CoV-2 virus at a dilution ratio of 1:100 in just 60 seconds, and at an economical 1:600 in-use dilution with a 10 minute contact time.

Biotechnology | 04/09/2020 | By Hemant

Godrej Appliances forays into the health and hygiene space with Godrej VIROSHIELD 4.0a

Godrej Appliances forays into the health and hygiene space with Godrej VIROSHIELD 4.0a

The COVID 19 pandemic has made a significant change in Indian consumer behavior when it comes to the priority accorded to safety and hygiene. Consumers are doing their best to protect themselves from the COVID 19 virus

Biotechnology | 20/08/2020 | By Darshana

PathogenDx receives NIH grant to develop more accurate and f efficient COVID-19 diagnostic testing technology

PathogenDx receives NIH grant to develop more accurate and f efficient COVID-19 diagnostic testing technology

PathogenDx Inc, an Arizona-based technology company which has developed an ultra-accurate DNA-based customized pathogen testing platform for the food, agricultural and health sectors, announced that it has received a second grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the National Institutes of Health (NIH)

Biotechnology | 19/08/2020 | By Darshana

Alembic Pharma gets US FDA approval for generic Levitra tablets

Alembic Pharma gets US FDA approval for generic Levitra tablets

Alembic Pharmaceuticals Limited has received final approval from the US Food & Drug Administration (FDA) for its abbreviated new drug application (ANDA) vardenafil hydrochloride tablets, 2.5 mg (base), 5 mg (base), 10 mg (base), and 20 mg (base)

Biotechnology | 06/08/2020 | By Darshana

FDA Revises Draft Guidance on Animal Drugs Intended for Minor Uses and Minor Species

FDA Revises Draft Guidance on Animal Drugs Intended for Minor Uses and Minor Species

The FDA encourages the development of safe and effective products to improve the health and well-being of all animals, including those for which there are limited options available because of the relatively small market they represent

Biotechnology | 20/07/2020 | By Darshana

NRDC invites proposals for COVID-19 technologies for scaling up and validation

NRDC invites proposals for COVID-19 technologies for scaling up and validation

The National Research Development Corporation (NRDC), under the Department of Science and Technology (DST), has invited proposals from the innovators under its Department of Scientific and Industrial Research (DSIR) grants-in-aid promotional programme for development of technologies for commercialization (PDTC) for up-scaling the COVID-19

Biotechnology | 17/07/2020 | By Darshana

GSK collaborates with Medicago to develop novel adjuvanted COVID-19 candidate vaccine

GSK collaborates with Medicago to develop novel adjuvanted COVID-19 candidate vaccine

GSK and Medicago, a biopharmaceutical company, announced a collaboration to develop and evaluate a COVID-19 candidate vaccine combining Medicago?s recombinant Coronavirus Virus-Like Particles (CoVLP) with GSK?s pandemic adjuvant system

Biotechnology | 09/07/2020 | By Darshana

Thermo Fisher Scientific launches serology testing kit for infectious diseases

Thermo Fisher Scientific launches serology testing kit for infectious diseases

Thermo Fisher Scientific, the world leader in serving science, today announced the availability of the Thermo Scientific MAS Omni Infectious Disease quality control sets for monitoring serological assays for analytes such as HIV 1&2, Hepatitis B & C virus, Syphilis and HTLV I/II

Biotechnology | 07/07/2020 | By Darshana 109

The European Commission has granted Orphan Medicinal Product Designation in the EU for MIV-818

The European Commission has granted Orphan Medicinal Product Designation in the EU for MIV-818

Medivir today announced that the European Commission, in accordance with the opinion from the European Medicines Agency (EMA), has granted orphan medicinal product designation in the EU for MIV-818 for the treatment of patients with hepatocellular carcinoma (HCC), the most common type of primary liver cancer

Biotechnology | 05/07/2020 | By Darshana

NPPA fixes retail prices of 14 formulations under DPCO 2013

NPPA fixes retail prices of 14 formulations under DPCO 2013

NPPA has fixed retail prices of 14 formulations under Drugs Prices Control Order (DPCO)- 2013 relating to 76th Authority meeting dated June 22, 2020<br />

Biotechnology | 03/07/2020 | By Darshana

 
 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology